5 research outputs found
Schematic representation of signaling cascade involved in hypoxia-inducible ephrin-A1 modulation of angiogenesis in tumor hypoxic microenvironment.
<p>Schematic representation of signaling cascade involved in hypoxia-inducible ephrin-A1 modulation of angiogenesis in tumor hypoxic microenvironment.</p
Effect of ephrin-A1-Fc on expression and phosphorylation of eNOS and Akt in HUVECs. HUVECs were exposed to ephrin-A1-Fc (1 µg/ml) for 0 h, 8 h, 24 h.
<p>Immunofluorescence (A), Real-time PCR (B) and Western blot analysis (C) demonstrated that ephrin-A1-Fc had no effect on eNOS expression of HUVECs (#, <i>P</i>>0.05, n = 3). D: Western blots demonstrating that P-eNOS<sub>Ser1177</sub> and P-Akt<sub>Ser473</sub> were up-regulated under ephrin-A1-Fc stimulation in a time-dependent manner. E: Quantity analysis of P-eNOS<sub>Ser1177</sub>. F: Quantity analysis of P-Akt<sub>Ser473.</sub> (*, <i>P</i><0.05, n = 4).</p
NO production in the supernatants of HUVECs after incubation with ephrin-A1-Fc (1 µg/ml) for 0 h, 24 h.
<p>Data showed a significantly increased NO production in the EA1-Fc group. (*, <i>P</i><0.05, n = 3).</p
Hypoxia up-regulated ephrin-A1 expression and soluble ephrin-A1 secretion in cancer cells.
<p>A: Western blots demonstrating that hypoxia elevated membrane bound ephrin-A1 expression in SCC-9 cells. B: Western blots demonstrating that hypoxia up-regulated soluble ephrin-A1 in supernatants of SCC-9 cells. SCC-9 cell density at 70–80% confluence was taken as 0 h when fresh culture medium was added. C: Cell rounding assay demonstrating that soluble ephrin-A1 in CM could activate EphA2 in U-251 GBM cells. Ephrin-A1(S), soluble ephrin-A1; N, normoxia conditioned medium group; H, hypoxia conditioned medium group.</p
PI3K/Akt mediated ephrin-A1-induced P-eNOS<sub>Ser1177</sub> in HUVECs.
<p>A: Representative Western blots for P-eNOS<sub>Ser1177</sub> and P-Akt<sub>Ser473</sub> from HUVECs that were starved in 0.1%BSA EBM-2 overnight and stimulated with ephrin-A1-Fc (1 µg/ml) for 30 min alone or together pre-treated with LY294002. B: Quantity analysis of P-Akt<sub>Ser473</sub>. C: Quantity analysis of P-eNOS<sub>Ser1177</sub>. (*, <i>P</i><0.05, n = 4) (#, <i>P</i>>0.05, n = 4).</p